Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein E. (Q43955453)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein E.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein E. (English)

1 reference

Europe PubMed Central

28 November 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Yi Xin Wang

1

1 reference

Europe PubMed Central

28 November 2017

Baby Martin-McNulty

2

1 reference

Europe PubMed Central

28 November 2017

Ling Yuh Huw

3

1 reference

Europe PubMed Central

28 November 2017

Valdeci da Cunha

4

1 reference

Europe PubMed Central

28 November 2017

Joe Post

5

1 reference

Europe PubMed Central

28 November 2017

Josephine Hinchman

6

1 reference

Europe PubMed Central

28 November 2017

Ronald Vergona

7

1 reference

Europe PubMed Central

28 November 2017

Mark E Sullivan

8

1 reference

Europe PubMed Central

28 November 2017

William Dole

9

1 reference

Europe PubMed Central

28 November 2017

Katalin Kauser

10

1 reference

Europe PubMed Central

28 November 2017

publication date

1 May 2002

1 reference

Europe PubMed Central

28 November 2017

Atherosclerosis

1 reference

Europe PubMed Central

28 November 2017

162

1 reference

Europe PubMed Central

28 November 2017

1

1 reference

Europe PubMed Central

28 November 2017

23-31

1 reference

Europe PubMed Central

28 November 2017

Cholesterol and mortality. 30 years of follow-up from the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900678-5

7 January 2021

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900678-5

7 January 2021

A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients witb hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900678-5

7 January 2021

Efficacy and safety of atorvastatin compared to pravastatin in patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900678-5

7 January 2021

Increased aortic stiffness assessed by pulse wave velocity in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900678-5

7 January 2021

Fatty streak initiation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900678-5

7 January 2021

Fatty streak expansion and maturation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900678-5

7 January 2021

Systemic nature of endothelial dysfunction in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900678-5

7 January 2021

Lovastatin prevents the impairment of endothelium dependent relaxation and inhibits accumulation of cholesterol in the aorta in experimental atherosclerosis in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900678-5

7 January 2021

The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900678-5

7 January 2021

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900678-5

7 January 2021

Mouse Models of Atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900678-5

7 January 2021

Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900678-5

7 January 2021

Type III hyperlipoproteinemia associated with apolipoprotein E deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900678-5

7 January 2021

The effects of diet and lovastatin on regression of fatty streak lesions and on hepatic and intestinal mRNA levels for the LDL receptor and HMG CoA reductase in F1B hamsters

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900678-5

7 January 2021

Inappropriate hepatic cholesterol synthesis expands the cellular pool of sterol available for recruitment by bile acids in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900678-5

7 January 2021

Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900678-5

7 January 2021

Efficacy of lipid profiles in prediction of coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900678-5

7 January 2021

Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900678-5

7 January 2021

From isolated vessels to the catheterization laboratory. Studies of endothelial function in the coronary circulation of humans

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900678-5

7 January 2021

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900678-5

7 January 2021

Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900678-5

7 January 2021

Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900678-5

7 January 2021

Atherogenesis during low level hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900678-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0021-9150(01)00678-5

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43955453&oldid=2104630124"